OFIX Orthofix Medical Inc.

Nasdaq orthofix.com


$ 14.96 $ 0.28 (1.91 %)    

Friday, 07-Nov-2025 15:59:55 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 14.96
$ 14.56
$ 13.88 x 10
$ 15.96 x 7
$ 14.56 - $ 15.20
$ 10.24 - $ 20.73
275,444
na
592.41M
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 03-05-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-06-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-05-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 02-24-2020 12-31-2019 10-K
25 10-28-2019 09-30-2019 10-Q
26 08-05-2019 06-30-2019 10-Q
27 05-06-2019 03-31-2019 10-Q
28 02-25-2019 12-31-2018 10-K
29 10-29-2018 09-30-2018 10-Q
30 08-06-2018 06-30-2018 10-Q
31 04-30-2018 03-31-2018 10-Q
32 02-26-2018 12-31-2017 10-K
33 10-30-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 10-31-2016 09-30-2016 10-Q
38 08-01-2016 06-30-2016 10-Q
39 04-28-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barrington-research-maintains-outperform-on-orthofix-medical-raises-price-target-to-18

Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and raises the price ...

 orthofix-medical-narrows-fy2025-sales-guidance-from-808000m-816000m-to-810000m-814000m-vs-813559m-est

Orthofix Medical (NASDAQ:OFIX) narrows FY2025 sales outlook from $808.000 million-$816.000 million to $810.000 million-$814.000...

 orthofix-medical-q3-adj-eps-020-sales-205600m-beat-200006m-estimate

Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $(0....

 stifel-reinstates-buy-on-orthofix-medical-announces-22-price-target

Stifel analyst Thomas Stephan reinstates Orthofix Medical (NASDAQ:OFIX) with a Buy and announces $22 price target.

 barrington-research-maintains-outperform-on-orthofix-medical-maintains-17-price-target

Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and maintains $17 pri...

 carlsmeds-personalized-spine-implants-get-significant-reimbursement-advantage

Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a ...

 orthofix-medical-affirms-fy2025-sales-guidance-of-808000m-816000m-vs-812800m-est

Orthofix Medical (NASDAQ:OFIX) affirms FY2025 sales outlook from $808.000 million-$816.000 million to $808.000 million-$816.000...

 orthofix-medical-q2-adj-eps-013-beats-049-estimate-sales-203121m-beat-196890m-estimate

Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $(0....

 barrington-research-initiates-coverage-on-orthofix-medical-with-outperform-rating-announces-price-target-of-16

Barrington Research analyst Michael Petusky initiates coverage on Orthofix Medical (NASDAQ:OFIX) with a Outperform rating an...

 jmp-securities-reiterates-market-perform-on-orthofix-medicalto-market-perform

JMP Securities analyst David Turkaly reiterates Orthofix Medical (NASDAQ:OFIX) from Market Perform to Market Perform.

 orthofix-medical-lowers-fy2025-sales-guidance-from-81800m-82600m-to-80800m-81600m-vs-82198m-est

Orthofix Medical (NASDAQ:OFIX) lowers FY2025 sales outlook from $818.00 million-$826.00 million to $808.00 million-$816.00 mill...

 canaccord-genuity-maintains-buy-on-orthofix-medical-maintains-24-price-target

Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and maintains $24 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION